“Safety of Abrocitinib in 3582 Patients With Moderate-to-Severe Atopic Dermatitis With Over 900 Patients Exposed for Almost 2 Years”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s150. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1989.